Nguyen et al. 21 highlighted its role in bladder cancer staging and prognosis, emphasizing the need for further investigation into potential therapeutic interventions targeting aromatase in bladder cancer treatment. Here, CYP19A1 is linked to urinary bladder carcinoma.